Festival of Biologics pavilion

Festival of Biologics pavilion

FOB ; festival of biologics ; congress ; 2024

October 13th-15th 2026

Basel, Switzerland

Festival of biologics congress

Festival of Biologics: Europe’s largest biotherapy event

The Festival of Biologics is organised every year 100% face-to-face by Terrapinn. Since the first edition in 2017, MabDesign has organised a shared pavilion every year at this key European event for the field of biotherapies, which will be held in Basel from 13th to 15th October. This congress is THE major European event for the biologics industry. Representative of the ecosystem, it has a strong focus on therapeutic antibodies, and is also open to advanced therapy drugs.

The Festival of Biologics is also an opportunity for MabDesign to organise an informal dinner with French players in the ecosystem, to encourage meetings and partnerships.

Biotech presentations will cover scientific and therapeutic innovations in the field, while exhibitors will present the tools, services and advice needed to develop and bring these innovations to market. A B2B platform will be available for meetings.

The shared pavilion organised by MabDesign is aimed at any company operating within the value chain of Innovative Therapy Medicines projects.

New for 2026: This year, the MabDesign Biotherapies Network pavilion will include a European extension. In addition to the ‘Choose France’ space, certified by Team France Export/Business France and hosting French companies, this additional space will enable us to welcome our European members.

Breakdown of participants at the Festival of Biologics
In 2025 :
participants
0 +
speakers
0
Start-ups
0
exhibitors
0
  • Biotherapies : Antibodies, cell and gene therapy, vaccines, checkpoint inhibitors, biosimilars

  • A wide range of indications: oncology, inflammation, autoimmune diseases, infectious diseases, neurodegenerative diseases, etc.

  • Themes: Discovery, development, clinical trials, manufacturing, fill and finish, financing, market access, diagnostics

Our offer

The MabDesign shared pavilion at the Festival of Biologics conference has been awarded the Choose France* label. It is a 70m² space entirely dedicated to French companies, with logistics fully managed by the MabDesign team, who also ensure a permanent presence at the stand. Our package includes a full conference pass, a dedicated 3m² space within the pavilion with your logo on the stand backdrop, and the option to display a poster.

Un second espace de 12m² accueille selon les mêmes conditions les sociétés européennes.

The pack
A dedicated 3m² space
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
1 full pass (the second at a reduced price)
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
Your logo on the stand background
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
A poster
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
Logistical support
Logistics 100% managed by MabDesign
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
A permanent stand presence to represent you
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
Preparation
The list of participants in Excel format, 1 month before the event
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress
List of Swiss biotech companies developing biotherapies
Advanced Tehrapies, Festival of biologics, NLS Days, World Vaccine congress

A glimpse of the shared pavilion

festival of biologics, FOB, pavillon partagé

With the support of

Elsa Kress

Head of business development

Jean-André Lapart

Business development manager

Discover our other international pavilions

The pavilions organised by MabDesign at international conferences enable you to optimise your international business development. Our pavilions give you the opportunity to exhibit at key conferences in your field of expertise, under optimum practical and financial conditions.

(6) 7-8 October 2026

Montréal, Québec

Jean-Roch Fabreguettes

MEARY

Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris

Jean-Roch Fabreguettes est un spécialiste de la recherche translationnelle et des phases précoces de développement clinique des médicaments de thérapie innovantes (MTI). Pharmacien, titulaire d’un doctorat de l’Université de Montpellier 1, il a travaillé plus de 25 ans dans le domaine et a contribué, pour des équipes académiques comme pour des start-ups, à la réalisation de plus de 30 programmes de recherche sur différents types de MTI : thérapie génique in vivo ou ex vivo, thérapie cellulaire, ingénierie tissulaire… Il est actuellement Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris. Le centre MEARY est une plateforme de l’Assistance Publique – Hôpitaux de Paris (AP-HP), dédiée à la fabrication de médicament de thérapie innovante expérimentaux. Laboratoire membre de l’ISCT, il est autorisé par l’ANSM et dispose d’un certificat GMP. A ce titre Jean-Roch Fabreguettes est impliqué dans le développement clinique et la fabrication de nombreux MTI : CAR-T cells, lymphocytes T régulateurs, cellules stromales mésenchymateuses…

Précédemment, Jean-Roch Fabreguettes a été expert Qualité (CMC) auprès de l’ANSM durant 9 ans et a conseillé différentes sociétés de biotechnologies. Il est un intervenant régulier pour l’Université Paris Cité et un membre actif de l’ISCT et de réseaux nationaux et internationaux sur les MTI (UNI-TC, Join4ATMP).